TravelingWiki Foundation Launches Beta of Generative AI Chatbot to Facilitate Greater Access to Air Travel for 20M Americans with Non Visible Disabilities After an Extensive Period of Development and Surrounding CES 2026 Alongside extensive work at CES 2026, TravelingWiki Foundation, the largest non-profit resource center globally assisting 20M Americans with Non Visible Disabilities with aviation […]

Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company's VASCEPA(R)/VAZKEPA(R) (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization GlobeNewswire January 09, 2026 DUBLIN and BRIDGEWATER, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today commented on

Aurora Mobile Partners with Xiaoe to Enhance Interaction Efficiency and Support Sustainable Growth in Private Domain Ecosystems GlobeNewswire January 09, 2026 SHENZHEN, China, Jan. 09, 2026 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that it

Predis.ai Announces Launch of New State-of-the-Art (SOTA) AI Models for Ad Videos New models enable businesses to scale high-quality video and image ads faster across social media platforms GlobeNewswire January 09, 2026 Predis.ai Logo LOS ANGELES, Jan. 09, 2026 (GLOBE NEWSWIRE) — Predis.ai today announced the launch of new state-of-the-art (SOTA) AI video generation models

iBio Announces $26 Million Private Placement GlobeNewswire January 09, 2026 SAN DIEGO, Jan. 09, 2026 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it has entered into a securities purchase agreement with existing healthcare-focused, high-quality institutional investors for a private placement (“PIPE”) financing that is expected to

MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026 GlobeNewswire January 09, 2026 SAN FRANCISCO and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) — MapLight Therapeutics, Inc. (MapLight) (Nasdaq: MPLT) today announced an update to the expected timing of topline results for its ongoing Phase 2 ZEPHYR and IRIS

VR Upsizes Brokered Private Placement Led by Centurion One Capital to $1,500,000 GlobeNewswire January 09, 2026 NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 09, 2026 (GLOBE NEWSWIRE) — VR Resources Limited (“VR” or the “Company“, TSXV: VRR) announces that due to significant

Athira Pharma Announces Name Change to LeonaBio, Inc. with New Ticker “LONA” New name to reflect recent transformative acquisition of rights to Phase 3 program in metastatic breast cancer and commitment to continued leadership, resilience and innovation GlobeNewswire January 09, 2026 BOTHELL, Wash., Jan. 09, 2026 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a

Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial at the 2026 ASCO Gastrointestinal Cancers Symposium GlobeNewswire January 09, 2026 Updated interim results with an additional ~13 weeks of follow-up since the prior update [212Pb]VMT-α-NET continues to be well-tolerated Updated efficacy analysis suggests durable disease control and deepening of

H&R Block Tax Pro Review Free for New Clients with Purchase of DIY Products Elevating the digital-first experience for consumers, powered by H&R Block's tax professional expertise GlobeNewswire January 09, 2026 KANSAS CITY, Mo., Jan. 09, 2026 (GLOBE NEWSWIRE) — H&R Block (NYSE: HRB) today announced it will include Tax Pro Review services at no